Log In
BCIQ
Print this Print this
 

HF10

  Manage Alerts
Collapse Summary General Information
Company Takara Bio Inc.
DescriptionMutant of herpes simplex virus type 1 (HSV-1)
Molecular Target Not applicable
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/15/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today